SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEvoke Plc Regulatory News (EVOK)

Share Price Information for Evoke Plc (EVOK)

Share Price is delayed by 15 minutes
Get Live Data
46.20    -0.55 (-1.18%)
Bid:
46.30
Ask:
46.50
Spread: 0.20 (0.432%)
Market Cap: £207.96m
EVOK Live PriceLast checked at - London Stock Exchange

Intraday Evoke Plc Share Chart

Board Change

21 Oct 2025 07:00

RNS Number : 1855E
Evoke PLC
21 October 2025
 

 

21 October 2025

 

evoke Plc

("evoke", the "Company", or the "Group")

 

Board Change

 

The board of directors (the "Board") of evoke (LSE: EVOK) announces today that, after more than five years at the Company, Lord Jon Mendelsohn has informed the Board of his decision to step down as Chair and Non-Executive Director with immediate effect. The Board thanks Jon for his significant and highly valued contributions to the Company since joining the Board in September 2020, including during his tenure as interim Executive Chair between 30 January to 16 October 2023.

The Board is pleased to announce that Mark Summerfield has been appointed as the permanent Non-Executive Chair of the Board with immediate effect. Mark joined the Board in September 2019 as a Non-Executive Director and is the chair of the Audit & Risk Committee and the Gaming Compliance Committee, and a member of the ESG Committee. Mark will step down as the chair of the Audit & Risk Committee and Limor Ganot will assume this role on an interim basis.

In addition, the Board announces that Anne de Kerckhove has been appointed as the permanent Deputy Chair of the Board with immediate effect. Anne joined the Board in November 2017 and will continue to serve as Senior Independent Director, as well as chairing the Nominations Committee and the ESG Committee, and serving on the Remuneration Committee.

Lord Jon Mendelsohn, Non-Executive Chair, commented:

"It has been a privilege to serve as the Chair of evoke. It has been a fantastic experience from shepherding the acquisition of William Hill International through to my tenure as interim Executive Chair and, more recently, working closely with the Board and executive team to develop and articulate evoke's long-term growth strategy. Having overseen the transformation of the business into one of the world's leading betting and gaming companies, now is the right time to hand over to Mark to steward evoke through its next important phase of growth and stability. I am incredibly proud of what we have achieved at the Company over the past five years and would like to thank my fellow Board members, the executive team, and the wider organisation for their utmost and unwavering commitment."

Per Widerström, Chief Executive Officer, commented:

"I would like to thank Jon for his exceptional leadership of the Board and for his support during my transition into the business. He has helped to guide the Company through a period of significant growth and transformation and his insight and collaboration will be missed.

I am looking forward to working with Mark and Anne in their new roles. Mark has such strong and deep institutional knowledge of the Company, the industry and our strategic priorities, and is ideally positioned to lead the Board and the Company through the next period of growth and development."

Mark Summerfield, Non-Executive Director, commented:

"It has been one of the highlights of my professional career to have partnered with Jon over the past few years and I will miss his dedication and insight. I look forward to working closely with my fellow Board members, including Anne as Deputy Chair, and the executive team to ensure the successful delivery of our strategy and create significant shareholder value."

As previously disclosed, the Group will announce its Q3 Trading Update on 28 October 2025.

This announcement is made pursuant to UK LR 6.4.6R.

 

Enquiries and further information:

evoke Plc

+44(0) 800 029 3050

Per Widerström, CEO

Sean Wilkins, CFO

Elizabeth Bisby, Company Secretary

 

Investor Relations

James Finney, Director of IR

 

Media

 

ir@evokeplc.com

 

 

evoke@hudsonsandler.com

Hudson Sandler

Alex Brennan / Andy Richards

+44(0) 207 796 4133

 

About evoke Plc:

evoke plc (and together with its subsidiaries, "evoke" or the "Group") is one of the world's leading betting and gaming companies. The Group owns and operates internationally renowned brands including William Hill, 888, and Mr Green. Incorporated in Gibraltar, and headquartered and listed in London, the Group operates from offices around the world.

The Group's vision is to make life more interesting and its mission is to delight players with world-class betting and gaming experiences.

Find out more at: https://www.evokeplc.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUAAVRVRURURA
Date   Source Headline
12th Jun 20263:48 pmRNSAwards granted under the LTIP
9th Jun 20263:30 pmRNSNotification of Transactions by PDMR
8th Jun 202612:18 pmRNSResults of AGM 8 June 2026
5th Jun 20267:00 amRNSRecommended all-share acquisition of evoke plc
4th Jun 20265:55 pmRNSHolding(s) in Company
1st Jun 20267:00 amRNSTotal Voting Rights
18th May 20264:35 pmRNSExtension of Firm Offer Deadline
11th May 20267:00 amRNSPublication of Notice of AGM
1st May 20267:00 amRNSTotal Voting Rights & Correction
30th Apr 20267:00 amRNSFY25 Results
28th Apr 20262:11 pmRNSDelay to publication of FY25 audited results
20th Apr 20267:01 amRNSStatement regarding media speculation
14th Apr 20267:00 amRNSBlock Listing Six Monthly Return
1st Apr 20269:56 amRNSTotal Voting Rights
31st Mar 202612:34 pmRNSHolding(s) in Company
18th Mar 20267:00 amRNSNotice of FY25 Results
2nd Mar 20267:00 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTotal Voting Rights
27th Jan 20267:00 amRNS2025 Post-close Trading Update
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
18th Dec 20257:00 amRNSNotice of FY 2025 Trading Update
17th Dec 20254:40 pmRNSHolding(s) in Company
10th Dec 202510:53 amRNSStrategic Review
1st Dec 20257:00 amRNSTotal Voting Rights
26th Nov 20255:45 pmRNSResponse to the UK Budget
3rd Nov 20257:00 amRNSTotal Voting Rights
28th Oct 20257:00 amRNSQ3 2025 trading update
21st Oct 20257:00 amRNSBoard Change
14th Oct 20257:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
7th Oct 20257:00 amRNSCommittee Update
1st Oct 20257:00 amRNSTotal Voting Rights
25th Sep 20257:00 amRNSNotice of Q3 2025 trading update
11th Sep 20257:00 amRNSPricing of an offering of Senior Secured Notes
1st Sep 20257:00 amRNSTotal Voting Rights
13th Aug 20257:00 amRNSH1 2025 Interim Results
4th Aug 20257:00 amRNSInvestor Meet Company Presentation
1st Aug 20257:00 amRNSTotal Voting Rights
22nd Jul 20257:00 amRNSH1 2025 Post-Close Trading Update
16th Jul 20257:00 amRNSNotice of H1 2025 trading update
1st Jul 20257:00 amRNSTotal Voting Rights
26th Jun 20257:00 amRNSDirector Declaration
18th Jun 20258:28 amRNSDirector Declaration
2nd Jun 20257:00 amRNSTotal Voting Rights
28th May 202512:36 pmRNSResults of AGM 28 May 2025
28th May 20257:00 amRNSEstablishment of a Technology Committee
27th May 20255:39 pmRNSPurchase of Annual Bonus shares
1st May 20257:00 amRNSTotal Voting Rights
30th Apr 20255:53 pmRNSNotification of Transactions by PDMR
25th Apr 20258:00 amRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.